Argentina In-vitro Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

The Argentina In-vitro Diagnostics Market is segmented by Technique, Product, Usability (Disposable and Reusable), Application, and End User

Market Snapshot

Study Period:


Base Year:


Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The Argentine IVD market is primarily driven by the high prevalence of chronic diseases. According to the World Heart Federation, non-communicable diseases (NCDs), including CVDs, are estimated to account for 81% of the total adult deaths in Argentina. Among those, CVDs accounts for around 35% of the deaths. Along with that, technological advancements in the country are propelling the growth of the IVD market. As the healthcare expenditure is increasing, the funding for healthcare has been increased, and this is helping the researchers and healthcare professionals to implement the novel technologies in the laboratories. According to the Journal of Cancer Epidemiology & Treatment, around three in every 100 women suffer from breast cancer in Argentina. The rising incidence of this disease is expected to contribute to the growth of the IVD market in the country.

Scope of the Report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases. In this report, a detailed analysis of the in vitro diagnostics market is presented, with specific attention toward diabetes and thalassemia. The in vitro diagnostics market has been segmented by technique, product, application, end user, and geography. The segmentation by technique includes POC diagnostics, molecular diagnostics, hematology, tissue diagnostics, microbiology, self-blood glucose monitoring, and other techniques. The segmentation by product includes instruments, consumables, and data management systems. The segmentation by application includes diabetes, cancer (oncology), cardiology, autoimmune disease, nephrology, drug testing, HIV/AIDS, and other applications.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Other Types
By Product
Other Products
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Autoimmune Disease
Other Applications
End Users
Diagnostic Laboratories
Hospitals & Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Haematology Segment is Expected to Exhibit a Positive Growth Rate Over the Forecast Period

The hematology tests are growing gradually and it is expected to do same in the forecasted period, this is due to the factors, such as increasing incidences of blood disorders, rapid technological advances in hematology, and emergence of high-throughput hematology analyzers, are expected to drive the market growth.

Hematology instruments have witnessed significant changes in design over the years and have evolved rapidly, from traditional instruments to present day automated instruments that provide fast and accurate results. Hematology In vitro diagnostic devices can be used in different disease conditions, such as autoimmune disease, cancer, diabetes mellitus, infectious disease, and in drug tests.

To understand key trends, Download Sample Report

Competitive Landscape

bioMérieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, and Bio-Rad Laboratories Inc. are some of the major players in the market. Major companies are focusing on increasing technological advancements, in order to address customer needs, like fully automated systems, which reduce manual processes and consumables, and also provide fast and accurate results.

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

      3. 4.2.3 Advanced Technologies

      4. 4.2.4 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Cumbersome Reimbursement Procedures

    4. 4.4 Porters Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Hematology

      5. 5.1.5 Other Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Nephrology

      7. 5.4.7 Other Applications

    5. 5.5 End Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals & Clinics

      3. 5.5.3 Other End Users


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Arkray Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 BioMerieux

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Danaher Corporation

      7. 6.1.7 QIAGEN

      8. 6.1.8 Roche Diagnostics

      9. 6.1.9 Siemens AG

      10. 6.1.10 Thermo Fisher Scientific

    2. *List Not Exhaustive

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports